Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM6B | O15054 | 1/20 | 0.61 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.55 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.45 |
| ▸ | KYNU | Q16719 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2865019 | 1.00 | KDM6B (0.61) | KDM6BGRIA2CTBP2ENPP2HIF1A | |
| SCHEMBL491093 | 0.85 | GRIA2 (0.58) | GRIA2CTBP2ENPP2HIF1ADRD2 | |
| SCHEMBL19369761 | 0.84 | GRIA2 (0.50) | KDM6BGRIA2CTBP2ENPP2HIF1A | |
| SCHEMBL9748709 | 0.83 | MDM2 (0.50) | KDM6BGRIA2CTBP2ENPP2HIF1A | |
| SCHEMBL8592637 | 0.81 | KDM6B (0.56) | KDM6BCTBP2LMNA | |
| SCHEMBL3347144 | 0.81 | KDM6B (0.56) | KDM6BCTBP2LMNA | |
| SCHEMBL19361721 | 0.81 | GRIA2 (0.44) | KDM6BGRIA2CTBP2ENPP2HIF1A | |
| SCHEMBL458080 | 0.80 | GRIA2 (0.82) | GRIA2HIF1AKDM4EPKMALOX15 | |
| SCHEMBL20702768 | 0.80 | KDM6B (0.54) | KDM6BTAAR1 | |
| SCHEMBL8953473 | 0.80 | SLC1A1 (0.62) | KDM6B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230398158-A1 | NEW COMPOSITION FOR TREATMENT OF SKIN CONDITIONS | LACTOBIO A/S (DK) | 2023-12-14 | — | — | US | claimed |
| EP-4240826-A1 | NEW COMPOSITION FOR TREATMENT OF SKIN CONDITIONS | Lactobio A/S (DK) | 2023-09-13 | — | — | EP | claimed |
| CN-116568292-A | Novel compositions for treating skin disorders | 莱托生物股份有限公司 | 2023-08-08 | — | — | CN | claimed |
| WO-2022096573-A9 | NEW COMPOSITION FOR TREATMENT OF SKIN CONDITIONS | LACTOBIO A/S (DK) | 2022-10-27 | — | — | WO | claimed |
| WO-2022096573-A1 | NEW COMPOSITION FOR TREATMENT OF SKIN CONDITIONS | LACTOBIO A/S (DK) | 2022-05-12 | — | — | WO | claimed |
| EP-3102053-A1 | SYSTEMS, METHODS, AND COMPOSITIONS FOR PROMOTING PATHOGEN CONTROL AND FOOD PRESERVATION | Micro-nature LLC (US) | 2016-12-14 | — | — | EP | claimed |
| US-20160338361-A1 | SYSTEMS, METHODS, AND COMPOSITIONS FOR PROMOTING PATHOGEN CONTROL AND FOOD PRESERVATION | MICRO-NATURE LLC (US) | 2016-11-24 | — | — | US | claimed |
| US-20160029667-A1 | IMPROVED MEAT SLURRY METHODS OF PRODUCTION AND COMPOSITIONS | MICRO-NATURE, LLC | 2016-02-04 | — | — | US | claimed |
| WO-2015120100-A1 | SYSTEMS, METHODS, AND COMPOSITIONS FOR PROMOTING PATHOGEN CONTROL AND FOOD PRESERVATION | MICRO-NATURE LLC (US) | 2015-08-13 | — | — | WO | claimed |
| EP-0770399-A2 | Additives enhancing topical actions of therapeutic agents | Van Scott, Eugene J., Dr. (US) | 1997-05-02 | — | — | EP | claimed |
| US-20240350561-A1 | PROBIOTIC BACTERIA COMPOSITION FOR INHIBITING FUNGAL PROLIFERATION | LACTOBIO A/S (DK) | 2024-10-24 | — | — | US | disclosed |
| EP-4392048-A1 | PROBIOTIC BACTERIA COMPOSITION FOR INHIBITING FUNGAL PROLIFERATION | Lactobio A/S (DK) | 2024-07-03 | — | — | EP | disclosed |
| CN-118139633-A | Probiotic composition for inhibiting fungal proliferation | 莱托生物股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| US-20230398158-A1 | NEW COMPOSITION FOR TREATMENT OF SKIN CONDITIONS | LACTOBIO A/S (DK) | 2023-12-14 | — | — | US | disclosed |
| EP-4240826-A1 | NEW COMPOSITION FOR TREATMENT OF SKIN CONDITIONS | Lactobio A/S (DK) | 2023-09-13 | — | — | EP | disclosed |
| EP-1873141-A1 | CALCIUM BIS[2S)-3-[3-(2S)-3-(4-CHLORO-2-CYANOPHENOXY)-2- FLUOROPROPOXY¨PHENYL]-2-ISOPROPOXYPROPIONATE] AND INTERMEDIATE THEREOF | Eisai R&D Management Co., Ltd. (JP) | 2008-01-02 | — | — | EP | disclosed |
| US-20070117866-A1 | Calcium bis [ (2S) - 3- [3-[ (2S) -3- (4-chloro-2-cyanophenoxy) -2- fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof | EISAI CO., LTD. (JP) | 2007-05-24 | — | — | US | disclosed |
| US-20070117866-A1 | Calcium bis [ (2S) - 3- [3-[ (2S) -3- (4-chloro-2-cyanophenoxy) -2- fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof | EISAI CO., LTD. (JP) | 2007-05-24 | — | — | US | disclosed |
| US-20070117866-A1 | Calcium bis [ (2S) - 3- [3-[ (2S) -3- (4-chloro-2-cyanophenoxy) -2- fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof | EISAI CO., LTD. (JP) | 2007-05-24 | — | — | US | disclosed |
| EP-0599819-B1 | Use of hydroxycarboxylic acids and derivatives for the preparation of topical dermatologic compositions for the treatment of wrinkles | SCOTT EUGENE J VAN (US) | 1997-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070117866-A1 | Calcium bis [ (2S) - 3- [3-[ (2S) -3- (4-chloro-2-cyanophenoxy) -2- fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof | CA2, CACNA1A, CACNA1C | KDM6B 2870/4885GRIA2 1598/4885CTBP2 1540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.